Thus, identifying phytochemicals with inhibitory activity against LDHB may yield innovative strategies for cancer therapy and other LDHB-related pathologies, such as cardiovascular, neurodegenerative, and chronic liver or kidney diseases [38]. The gene discussed is LDHB; the disease is kidney disorder.